The Mitsubishi Pharma Group changed its name to The Tanabe Pharma Group on 1st December 2025. All affiliates that previously bore the Mitsubishi Tanabe name changed their names accordingly to drop the Mitsubishi name
Collaborative working is generally between one or more pharmaceutical companies, which either enhances patient care or is for the benefit of patients, or alternatively benefits the NHS. In accordance with clause 20 of the ABPI Code of Practice, the Tanabe Pharma Group will publish an executive summary of any collaborative working (including joint working) agreements below before arrangements are implemented.
We have no Collaborative Working projects to announce at this time.
Terms and Privacy
Contact Us
TANABE Pharma Europe Ltd
Dashwood House
69 Old Broad Street
London
EC2M 1QS
United Kingdom